EcoDrugPlus

Opioid Receptor, Delta 1b

Ensembl ID : ENSSAUG00010007866
Gene Symbol: OPRD1B
1 Cross references
191 Possible Orthologues:

Opioid Receptor, Delta 1b

Ensembl ID : ENSSAUG00010014509
Gene Symbol: OPRD1B
1 Cross references
179 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSSAUG00010010024
Gene Symbol: OPRK1
1 Cross references
197 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSSAUG00010000360
Gene Symbol: OXTR
3 Cross references
183 Possible Orthologues:

Oxytocin Receptor A

Ensembl ID : ENSSAUG00010005815
Gene Symbol: OXTRA
1 Cross references
191 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSSAUG00010023506
Gene Symbol: PTH1R
3 Cross references
196 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSSAUG00010025277
Gene Symbol: PPARD
3 Cross references
392 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSSAUG00010013475
Gene Symbol: PPARG
3 Cross references
386 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSSAUG00010011188
Gene Symbol: LOC115595386
3 Cross references
383 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSSAUG00010026739
Gene Symbol: LOC115586305
3 Cross references
396 Possible Orthologues:

Phosphatidylinositol 3-Kinase Regulatory Subunit Gamma-Like

Ensembl ID : ENSSAUG00010006682
Gene Symbol: LOC115571904
3 Cross references
189 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSSAUG00010006864
Gene Symbol: PIK3CA
3 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).